Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intes... (Vice President and Chief Medical Officer...)

Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain

Date:10/6/2008

Vice President and Chief Medical Officer at Ironwood.

"These novel findings provide valuable insight into the possible role of cGMP in alleviating intestinal pain and may explain the reduction in intestinal pain observed in patients with IBS-C treated with linaclotide in our Phase 2b studies," said Mark Currie, Ph.D., Senior Vice President, R&D and Chief Scientific Officer at Ironwood.

About Linaclotide

Linaclotide is a first-in-class compound currently being evaluated for the treatment of IBS-C, chronic constipation (CC), and other gastrointestinal disorders. Linaclotide was designed to exert its effect on the intestine with minimal systemic exposure. Linaclotide is an agonist of guanylate cyclase type-C, a receptor found on the lining of the intestine. Linaclotide demonstrated proof of concept in a comprehensive Phase 2b program, comprised of two clinical studies in over 700 patients with either IBS-C or CC. In patients with IBS-C, linaclotide reduced abdominal pain and relieved constipation-the hallmarks of the condition-throughout the 12-week treatment period. In patients with CC, linaclotide reduced constipation throughout the 4-week study period. Linaclotide was well tolerated at all doses in both Phase 2b studies, with the most common adverse event being diarrhea. A United States patent covering linaclotide composition of matter expires in 2025. In September 2007, Ironwood and Forest Laboratories entered into a 50/50 collaboration to co-develop and co-promote linaclotide in the United States. Ironwood retains exclusive rights to linaclotide outside of North America.

About Irritable Bowel Syndrome (IBS)

One out of six adults in developed countries suffers from IBS, a chronic condition marked by abdominal pain and disturbed bowel function. IBS accounts for 12% of adult visits to primary care physicians and is the most common disorder diagnosed by gastroenterologists. Healthcare costs associated with IBS exceed $25 billion ann
'/>"/>

SOURCE Ironwood Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3
Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
3. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
4. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
5. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007

Post Your Comments:

(Date:5/21/2013)... WESTBURY, N.Y. , May 21, 2013 Vasomedical, Inc. ... specializing in the design, manufacture and sale of medical devices ... today that Dr. Jun Ma , President ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...

(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Technologies for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES ... study is to offer synopsis of the ...

(Date:5/21/2013)... Fla. , May 21, 2013 Janssen ... safety results from the global Phase 3 PROMISE ... inhibitor simeprevir (TMC435) led to sustained virologic response ... in 79 percent of treatment-experienced genotype 1 chronic ... including all stages of liver fibrosis, when administered ...

[0] Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference [0] Global Markets and Technologies for Optical Coherence Tomography (OCT)[0] Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients

... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will ... Conference on Monday, September 20, 2010. The presentation is ... be accessed through the Company,s web site, www.regeneron.com ... of the presentation will be available after the live ...

... Shield Healthcare, a leading provider of medical supplies for ... annual story contest on "What Makes Caregiving Rewarding?" designed ... home healthcare professionals, featuring celebrity contest judge, Sandra Mitchell ... caregiving is a demanding job. A significant number of ...

Cached Medicine Technology:Shield Healthcare Announces 10th Annual Caregiver Story Contest 2

Regeneron Announces Presentation at the UBS Global Life Sciences Conference Shield Healthcare Announces 10th Annual Caregiver Story Contest

(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... some of the changes brought about by the disorder ... New research has found that people with diabetes who ... risk of having a severe low blood sugar (hypoglycemia) ... people with diabetes who aren,t depressed. "Depression ...

(Date:5/21/2013)... long been known for their health benefits, and ... like anti-cancer drugs are delivered to specific tumor ... how to create nanoparticles using natural lipids derived ... them as drug delivery vehicles. UofL scientists Huang-Ge ... team today (May 21, 2013), published their findings ...

(Date:5/21/2013)... Schaumburg, IL (PRWEB) May 21, 2013 ... administration for large, medium, and small organizations, will be ... featuring an experts team from Findley Davies. The presentation ... is up-to-date and in compliance with new Health Care ... ideas to engage employees. , “Benefit Express regularly ...

(Date:5/21/2013)... May 21, 2013 Dr. Francine Kaufman , ... she used with her patients in the 1980s: It weighed several ... For the most part, it could only be used in the ... years since then, and the advantages are greater as well. The ... outside of the body, often on a belt or a pocket. ...

(Date:5/21/2013)... 21, 2013 A plastic surgery ... for plastic surgery SEO services following an Internet ... to name the “Best Plastic Surgery SEO Services”. ... outcome was predictable. Well-known in the plastic surgery ... patients than any other selection based on superior ...

Breaking Medicine News(10 mins):Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2 Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3 Health News:UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery 2 Health News:Benefit Express to Host Workplace Wellness Webinar 2 Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2 Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3 Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4 Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2

[0] Depression May Raise Low Blood Sugar Risk in Diabetics [0] UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery [0] Benefit Express to Host Workplace Wellness Webinar [0] Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives [0] JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO

... from University of Texas observed that Viagra could be ... are accurate, but based on a small experiment in ... translate directly to people with chronic heart and lung ... be useful in treating people with pulmonary hypertension (caused ...

... who were student athletes and have always been slim ... is a rare and invariably fatal neurological condition. It's ... baseball player whose career was cut short by it. ... athletic and developing ALS, as well as motor neurone ...

... a new study in the American Journal of Clinical Nutrition ... role in preventing the build up of plaque in the ... shown antioxidant vitamins can protect against the formation of plaque ... who were already diagnosed with heart disease or who had ...

... new techniques to exercise, one of them being, fitness balls ... more like a children's toy, but they're a powerful new ... of 55 to 65 centimetres diameter. ,The balls ... you have to work your muscles to keep your balance. ...

... a breakthrough discovery, American researchers have found some of the ... the womb. There have always been theories that unborn babies ... is read to or played music while still in the ... has been questionable in the past because there has been ...

... autism. A study in this week's issue of British ... likely than those without it to have had gastrointestinal ... University identified 90 children with autism and compared them ... histories, including when they had the measles, mumps, and ...

Cached Medicine News:

Viagra for heart and lung patients Link between athleticism and neurological disease Vitamin E supports Female Hearts A new way to exercise Unborn babies respond to light Latest discovery on Autism

The ImmunoWELL TPO IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroid peroxidase (microsome) in serum and is used as ...

... The ImmunoDOT Autoimmunity Screening Panel 4 ... for screening and detection of autoantibodies ... (SS-A, SS-B, RNP/Sm, and Sm) in ... aid in the diagnosis of systemic ...

The 8500 is an extremely reliable portable pulse oximeter, requiring no periodic maintenance or calibration....

Rad-5 signal extraction pulse oximeter™...

Medicine Products:

ImmunoWELL TPO IgG Quantitative Test ImmunoDOT Autoimmunity Screening Panel 4 Pulse Oximeter Model: THS 8500 Rad-5 signal extraction pulse oximeter™